These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1033672)

  • 1. Techniques of argon laser photocoagulation of diabetic disk new vessels.
    Little HL; Zweng HC; Jack RL; Vassiliadis A
    Am J Ophthalmol; 1976 Nov; 82(5):675-83. PubMed ID: 1033672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argon Laser Photocoagulation of proliferative diabetic retinopathy.
    Little HL
    Int Ophthalmol Clin; 1976; 16(4):79-103. PubMed ID: 1033166
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of proliferative diabetic retinopathy. Long-term results of argon laser photocoagulation.
    Little HL
    Ophthalmology; 1985 Feb; 92(2):279-83. PubMed ID: 2580259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photocoagulation for optic disc new vessels in diabetes mellitus.
    Asher R; Hunt S; Hamilton AM; Townsend C; Blach RK; Khoury D; Kohner EM; Morris DV
    Int Ophthalmol; 1981 Mar; 3(2):79-85. PubMed ID: 6164659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further observations on argon laser photocoagulation of diabetic retinopathy.
    Zweng HC; Little HL; Peabody RR
    Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(4):990-1004. PubMed ID: 4677399
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.
    Plumb AP; Swan AV; Chignell AH; Shilling JS
    Br J Ophthalmol; 1982 Apr; 66(4):213-8. PubMed ID: 6175340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
    Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 1. Effect on disc vessels, visual fields, and visual acuity.
    Hamilton AM; Townsend C; Khoury D; Gould E; Blach RK
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):87-92. PubMed ID: 6192562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal photocoagulation of retinovitreal neovascularization.
    L'esperance FA
    Int Ophthalmol Clin; 1976; 16(4):127-43. PubMed ID: 1033161
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of argon laser and krypton laser in the treatment of diabetic optic disc neovascularisation.
    Schulenburg WE; Hamilton AM; Blach RK
    Br J Ophthalmol; 1979 Jun; 63(6):412-7. PubMed ID: 572699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argon laser photocoagulation for treatment of advanced diabetic retinopathy.
    Patz A; Schatz H; Ryan SJ; Berkow JW; Lazarus MG
    Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(4):984-9. PubMed ID: 4677398
    [No Abstract]   [Full Text] [Related]  

  • 12. Time span of regression or disappearance of optic disk neovascularisation in proliferative diabetic retinopathy after panretinal argon laser photocoagulation and results over a two-year follow-up.
    Theodossiadis GP; Ismiridis KJ
    Fortschr Ophthalmol; 1987; 84(5):465-7. PubMed ID: 2448214
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy.
    Blankenship GW
    Ophthalmology; 1988 Feb; 95(2):170-7. PubMed ID: 2459641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
    Blankenship GW
    Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dye laser treatment in proliferative diabetic retinopathy and maculopathy.
    Atmaca LS; Idil A; Gündüz K
    Acta Ophthalmol Scand; 1995 Aug; 73(4):303-7. PubMed ID: 8646573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision.
    Birch J; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):93-9. PubMed ID: 6192563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Critical evaluation of the treatment of diabetic retinopathy based on personal experience].
    Szweda E; Leszkowska M; Olejarz E; Kaliska G
    Klin Oczna; 1992 Jan; 94(1):27-8. PubMed ID: 1635368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral photocoagulation in the treatment of disc neovascularization.
    Woldoff HS; Gerber M
    Ann Ophthalmol; 1978 Aug; 10(8):1087-99. PubMed ID: 697282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photocoagulation in diabetic retinopathy.
    Arribas NP; Johnston GP; Okun E
    Int Ophthalmol Clin; 1976; 16(4):59-77. PubMed ID: 1033165
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative use of diode and argon laser for panretinal photocoagulation in diabetic retinopathy].
    Ulbig MW; Hamilton AM
    Ophthalmologe; 1993 Oct; 90(5):457-62. PubMed ID: 8219631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.